Release Date: 12/02/20 16:43 Summary: Director Appointment/Resignation Price Sensitive: No Download Document 924.91KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%